NovaBay Pharmaceuticals Inc (NBY) Stock
NBY is no longer traded. NovaBay Pharmaceuticals was delisted from the NYSE American in June 2026.
Prices on this page are historical; the last trade was June 4, 2026 at $1.21.
NovaBay Pharmaceuticals stock price history
NBY final trading statistics
- Final close
- $1.21
- Final trading day
- Jun 4, 2026
- Market cap at delisting
- $32.22M
- Shares outstanding
- 26.63M
- Final 52-week range
- $0.43 – $19.95
- Avg. volume (final 3 mo.)
- 409,182
- All-time high (split-adj.)
- $405885.06 · Nov 2007
- All-time low (split-adj.)
- $1.15 · Jun 2026
- Return since IPO
- -80.1%
- Beta
- 0.16
- Book value / share
- -$0.92
- Price / book
- -1.32
NovaBay Pharmaceuticals annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $0.00 | -$22.1M | — |
| FY2024 | $9.78M | -$7.2M | -$4.10 |
| FY2023 | $10.46M | -$9.6M | -$3.19 |
| FY2022 | $14.40M | -$10.6M | -$7.43 |
| FY2021 | $10.20M | -$5.8M | -$5.25 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About NovaBay Pharmaceuticals Inc
NovaBay Pharmaceuticals, Inc. engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
NovaBay Pharmaceuticals stock FAQ
What happened to NovaBay Pharmaceuticals stock?
NovaBay Pharmaceuticals stock was delisted from the NYSE American. Its final close was $1.21 on June 4, 2026.
Is NBY stock still trading?
No. NBY was delisted from the NYSE American in June 2026 and no longer trades on a U.S. exchange.
What was the last price of NBY stock?
NBY closed at $1.21 on its final trading day, June 4, 2026, for a market value of about $32.22M.
What were NovaBay Pharmaceuticals's revenue and earnings in its last full fiscal year?
NovaBay Pharmaceuticals reported revenue of $0.00 and net income of -$22.1M in fiscal 2025, its last full year as a public company.
When did NovaBay Pharmaceuticals go public?
NovaBay Pharmaceuticals Inc stock began trading on October 26, 2007.